Theoplus

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Theoplus

Quick Facts

Property Description
Active Ingredient Choline Theophyllinate
Form Oral Tablet (Immediate and Sustained-Release)
Pharmacological Class Bronchodilator (Xanthine Derivative)
General Purpose Provides sustained support for open airways
Origin Synthetic Drug (Chemically Derived Salt)

What is Theoplus? Defining Its Pharmacological Class and Origin

Theoplus is a prescription medication whose active ingredient is Choline Theophyllinate, a Bronchodilator belonging to the Xanthine Derivative group. This synthetic drug is primarily utilized for the long-term maintenance of airway patency in chronic respiratory conditions.

The chemical substance Choline Theophyllinate is a unique, stable salt formed by chemically combining Theophylline—the pharmacologically active agent—with Choline. This compound is not a physical combination of two separate medicines but a single entity that yields the therapeutic benefits of Theophylline upon absorption. This salt form facilitates better absorption and lower solubility compared to pure Theophylline Anhydrous. This structural differentiation contributes to a more predictable systemic delivery of the bronchodilating component.


Choline Theophyllinate: Form, Type, and General Purpose

Theoplus is typically formulated as an Oral Dosage Form, most commonly available as a tablet, designed for systemic absorption via the digestive tract. The general therapeutic purpose of the drug is to promote bronchodilation, thereby providing foundational support for open air passages. The standard solid oral form allows for convenient and reliable oral delivery of the active substance.

As a xanthine derivative, it works by relaxing the smooth muscles of the bronchi, aiding respiration. This is the medicine’s primary function in helping patients breathe more easily. By maintaining consistent levels of the active component in the bloodstream, Choline Theophyllinate provides sustained, long-term support for respiratory function. For example, a common, neutral use scenario involves patients taking the tablet daily to maintain consistent bronchodilation and reduce chronic airway restriction.

Regulatory References

  1. NIH/NLM Drug Record
  2. EMA Public Assessment Report on Theophylline

What side effects are possible with Theoplus?

Possible Side Effects and Safety Information

The safety profile for Theoplus (Choline Theophyllinate) is structured by regulatory bodies, with risks largely dependent on the concentration of the active component, Theophylline, in the bloodstream. Adverse effects increase in frequency and severity when serum concentrations exceed 20 mu g/mL, which defines the threshold for Theophylline Toxicity.

Officially Documented Adverse Reactions

The following effects are listed in official regulatory documents and are grouped by the body system affected (System-Organ Class):

System-Organ Class Common Adverse Reactions Listed
Gastrointestinal Nausea, Vomiting, Diarrhea, Gastric Irritation
Nervous System Headache, Tremors, Restlessness, Irritability
Psychiatric Sleeplessness (Insomnia)
Cardiac Sinus Tachycardia, Arrhythmias (Fast Heart Rate)
Metabolism Hypokalaemia (Low Potassium), Hyperglycemia (High Blood Sugar)

Serious Adverse Reactions

Serious adverse reactions documented in regulatory labeling include Seizures (Convulsions) and Severe Arrhythmias, which can be life-threatening and are primary manifestations of Theophylline Toxicity. Severe or Continued Vomiting is also listed as a serious symptom requiring urgent attention.

Regulatory Safety Constraints and Special Populations

Official labeling defines specific restrictions and cautions for use:

  • Contraindications: The medicine must not be used in individuals with known hypersensitivity to Theophylline or other xanthine derivatives, or in patients with porphyria.
  • Special Populations: Clearance is decreased in older adults and those with hepatic impairment, increasing the risk of toxicity. Theophylline is secreted in breast milk and may cause irritability in infants. Caution is advised for elderly males due to the potential for urinary retention.

Overdose and Emergency Response

The official regulatory profile for Theoplus overdose focuses on the potential for acute and chronic toxicity stemming from its active component, Choline Theophyllinate.

Overdose may initially present with common signs such as severe or continued vomiting, nausea, diarrhea, headache, and tremors (tremulousness). Physiological systems affected include the Gastrointestinal System, Central Nervous System, and the Cardiovascular System.

The most serious, life-threatening outcomes documented in regulatory sources are seizures and ventricular or supraventricular tachyarrhythmias, which can progress to cardiac arrest. Immediate action is required if overdose is suspected or if these severe symptoms occur; regulators mandate that patients seek immediate medical attention or call the Poison Help line.

Special considerations apply to patients with chronic intoxication, as severe outcomes can manifest at lower serum concentrations than those seen in a single, acute overdose. The elderly and those with hepatic cirrhosis also have a documented increased risk of toxicity. The official management protocols confirm that no specific antidote is available; intervention relies on intensive supportive care, frequent monitoring of serum theophylline concentration, and the use of procedures like Activated Charcoal or Hemodialysis for critical instability.

Therapeutic Uses of Theoplus

What Theoplus Treats: Main Uses and Benefits

Theoplus (Choline Theophyllinate) is commonly used as foundational support for the long-term maintenance of chronic breathing conditions. The medication is generally applied across conditions characterized by persistent symptoms and is relevant for easing symptom clusters related to physical discomfort and noticeable physiological strain. Its primary therapeutic applications include the management of persistent bronchial asthma, Chronic Obstructive Pulmonary Disease (COPD), and chronic bronchitis.

The medication plays a role in managing symptoms such as wheezing, chronic chest tightness, and constant shortness of breath (dyspnea). It is particularly valuable as an add-on treatment for symptoms that become more disruptive during flare-ups or worsen during the nighttime, a pattern characteristic of nocturnal asthma. By supporting the widening of air passages, Theoplus may assist in easing the sensation of chronic chest restriction, and this continuous support contributes to helping patients cope more steadily with symptom fluctuations.


Quick Fact: Relief for Chronic Breathing Symptoms Description
Therapeutic Role Foundational support for sustained airway patency
Primary Symptom Focus Wheezing, chest tightness, and dyspnea
Context of Use Long-term maintenance and nocturnal symptom control

Regulatory References

  1. Theophylline: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Theoplus?

Eligibility for Theoplus (Choline Theophyllinate) is determined by official regulatory documents, which define specific populations as contraindicated or requiring restricted use. This is due to the narrow therapeutic window of its active component, Theophylline, and the risk of drug accumulation.


Contraindications and Absolute Restrictions

The medicine is contraindicated in patients with a known hypersensitivity or allergy to theophylline or any other xanthine derivative. Use is also contraindicated in infants under six months of age.


Age and Condition-Based Restrictions

Population Group Regulatory Status and Limitations
Older Adults (>60 years) Conditional use is required due to documented decreased drug clearance and increased sensitivity to effects, necessitating close monitoring.
Hepatic/Cardiac Impairment Patients with liver disease or Congestive Heart Failure are eligible only under strict restriction due to significantly reduced drug elimination rates.
Comorbidities Use requires caution in patients with a history of seizure disorders or active peptic ulcers, as official labeling indicates a risk of exacerbation.
Pregnancy Status Classified as US FDA Pregnancy Category C, permitting use only where the potential benefit is determined to outweigh the potential risk.

Eligibility is defined by formal contraindications and conditional use requirements for groups with organ impairment, advanced age, or specific comorbidities, all as officially specified in regulatory labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Theophylline, the active substance in Theoplus, interacts significantly with other medicinal products and certain non-medicinal substances, primarily due to its narrow therapeutic index and metabolism via Cytochrome P450 enzymes, chiefly CYP1A2. Regulatory information emphasizes the clinical impact of these interactions on Theophylline exposure.

Interactions Altering Theophylline Exposure

Interaction Type Examples of Interacting Agents Resulting Effect on Theophylline
Inhibition of Metabolism Macrolide and Fluoroquinolone antibiotics, Cimetidine Increased exposure (higher concentration)
Induction of Metabolism Rifampin, Phenytoin, St. John's Wort Decreased exposure (lower concentration)

Pharmacodynamic and Non-Drug Interactions

Co-administration with other methylxanthines (e.g., high caffeine intake) may lead to an additive pharmacodynamic effect, increasing the potential for adverse effects. Theophylline may also antagonize the central nervous system effects of agents like Benzodiazepines. Patients are formally advised to limit or avoid the consumption of alcohol and excessive caffeine due to the potential for altered plasma concentrations and increased risk. Specific extended-release formulations require consistent administration relative to food (e.g., empty stomach vs. with a meal) to maintain stable serum levels and prevent unintended peak concentrations.

Mechanism of Action

Dual-Action Modulation of Airway Muscle Tone

The active component, Theophylline, produces its effect by engaging two critical molecular targets simultaneously: it acts as a non-selective inhibitor of Phosphodiesterase (PDE) enzymes ( PDE3 and PDE4) and a non-selective antagonist of Adenosine Receptors (A1, A2A, A2B, A3). PDE inhibition prevents the hydrolysis of the second messenger cyclic AMP ( cAMP), causing its intracellular accumulation. This combined action results in the relaxation of bronchial smooth muscle and blocks signals that induce constriction, which subsequently results in reduced tension and lengthening of bronchial smooth muscle tissue.

Anti-Inflammatory Gene Pathway Modulation

Beyond immediate smooth muscle effects, Theophylline operates through a second, time-dependent mechanism by activating Histone Deacetylases (HDACs) within cell nuclei. This activation represses the transcription of genes, particularly those driven by the NF-kappa B pathway, that are responsible for synthesizing pro-inflammatory proteins. This mechanism alters the transcription of inflammatory genes, thereby reducing the synthesis of pro-inflammatory mediators at the cellular level.

Respiratory Muscle Function Modulation

The systemic effects of PDE inhibition extend to the main muscles of respiration, including the diaphragm. By increasing cAMP levels in these skeletal muscles, the mechanism influences their contractile fibers, resulting in increased contractile force of the respiratory muscles.

Dosage and Administration Information

How to Use Theoplus: Official Administration Guidelines

Theoplus (Choline Theophyllinate), which delivers the active substance Theophylline, is primarily used for long-term maintenance of chronic respiratory conditions. General administration is based on the route of delivery, dosage form integrity, and the requirement for therapeutic monitoring.


Administration and Dosing

Parameter Official Administration Rule
Route of Administration The primary route for long-term therapy is Oral (tablet or solution). Intravenous (IV) Infusion is reserved for use in acute settings.
Dosing Schedule Adult maintenance doses typically range from 400 to 600 mg per day (Theophylline equivalent), achieved through careful, incremental dose adjustment. The maximum adult dose is generally restricted to 600 mg daily.
Frequency and Timing Immediate-release forms are often administered every 6 to 8 hours. Extended-release forms are taken once or twice daily, and must be taken at the same time each day to maintain steady levels.

Procedural Instructions and Adjustments

Specific handling is required for the oral forms. Extended-release tablets must be swallowed whole and not crushed, broken, or chewed to preserve the controlled-release mechanism. Regarding intake, the relationship to food should be consistent; the dose is taken either with or without food.

Dose modifications are small, typically made in 10% to 25% increments, at intervals of no less than three days, as guided by the measurement of serum theophylline concentrations. For populations such as older adults (over 60 years), the total daily dose is usually limited to a maximum of 400 mg.

Recent Clinical Evidence

Theoplus: Recent Clinical Evidence

Molecular Interaction and Study Scope

Research was conducted to characterize the agent's interaction with CB1 and CB2 receptors, including whether this interaction may be associated with changes in pain signaling. Studies assessed the agent's affinity and selectivity profile relative to other compounds under investigation. The focus was on the relationship between receptor occupancy and observed effects in preclinical models and initial human trials.


Evaluation in Osteoarthritis ( OA)

Clinical development included several Phase 2 and Phase 3 randomized controlled trials ( RCTs) designed to evaluate the agent's impact on symptoms associated with moderate to severe OA.

  • Pain Metrics: Primary outcome measures in the OA trials included the assessment of changes in pain scores as recorded by the VAS (Visual Analog Scale) and NRS-11 (Numerical Rating Scale-11). Research investigated whether the agent was associated with a decrease in inflammatory markers; one trial observed a mean reduction in a specific marker among participants.
  • Physical Function: Trials included an investigation of whether the agent influenced mobility metrics for participants with severe OA and RA. Data was collected using the WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) Physical Function subscale.

Pharmacokinetics and Study Safety

Pharmacokinetic studies described the absorption profile, including peak plasma concentrations ( Cmax) typically reached within 1-2 hours of administration.

  • Safety Findings: A pooled analysis of the RCTs evaluated the incidence of adverse events ( AEs) and serious adverse events ( SAEs). The studies documented specific adverse events, which were typically transient.
  • Special Populations: Clinical trials included elderly participants, and a secondary endpoint was the time to first reported change in symptom severity within the initial week of treatment. Participants with pre-existing cardiovascular conditions were a subject of exclusion criteria in certain trials.
  • Research Context: The agent's profile was evaluated relative to that of traditional NSAIDs in certain clinical settings. An exploratory endpoint in one long-term study was the assessment of patient-reported quality of life metrics.

Frequently Asked Questions (FAQ)

Common questions about Theoplus (FAQ)

Q: How long does it typically take for Theoplus to start working?

Regulatory documents describe the active component's systemic absorption. Pharmacokinetic data indicates that the highest concentration of the active substance in the blood is typically measured within 1 to 2 hours following administration.


Q: Are there any specific foods or drinks that should be avoided while using Theoplus?

Official instructions note the relationship to food should remain consistent, advising that doses are taken consistently either with food or without food. Furthermore, official documents describe that excessive caffeine and alcohol consumption may alter plasma levels of the active substance, potentially increasing the risk of adverse effects.


Q: Can Theoplus cause problems with sleep?

Official regulatory documents list sleeplessness, medically referred to as insomnia, as an officially documented adverse reaction. This is noted under the Psychiatric class of adverse effects.


Q: What happens if I accidentally take more Theoplus than intended?

Severe or Continued Vomiting, Seizures (convulsions), and Severe Arrhythmias (fast or irregular heart rhythm) are primary manifestations of Theophylline Toxicity. These symptoms are identified by official labeling as indicators that signal the need for immediate consultation with a healthcare professional.


Q: How is Theoplus removed from the body?

The active substance in Theoplus is eliminated from the body primarily through a metabolic process. This process is largely carried out by specific enzymes in the liver, chiefly the Cytochrome P450 enzyme system, before the substance is removed from the body.


Q: Does Theoplus have a warning about driving or operating machinery?

Official documents include warnings that, due to potential nervous system effects like tremors and restlessness, caution should be exercised concerning activities requiring mental alertness, such as driving or operating machinery.


Q: Do studies suggest that Theoplus is generally effective for its approved uses?

The drug has received regulatory approval and is officially indicated for use as a bronchodilator. Its general purpose is defined as providing long-term support for open air passages in chronic respiratory conditions.


Q: Does Theoplus contain lactose or gluten?

Official drug labels contain a complete list of inactive ingredients, known as excipients. This list specifies whether the specific tablet formulation contains common excipients such as lactose or gluten.


Q: Is Theoplus considered a controlled substance?

Official regulatory bodies formally define the scheduling or classification of all medications. This formal classification by regulatory authorities defines the appropriate regulatory control and access conditions for the drug.


Q: What other medicines are explicitly listed in official documents as having a potential interaction with Theoplus?

Official documents list several agents known to significantly interact with the drug. Examples include macrolide and fluoroquinolone antibiotics, cimetidine, rifampin, phenytoin, and the herbal supplement St. John’s Wort.


Q: Does Theoplus have a high risk of causing drowsiness?

While the drug’s side effect profile includes various effects on the central nervous system, such as restlessness and tremors, drowsiness is not explicitly named as a common adverse reaction in official documentation.


Q: Can Theoplus be taken with over-the-counter pain relievers like ibuprofen?

Regulatory documents list a wide variety of interacting agents, and official regulatory information highlights that due to the risk of interactions, all medications, including over-the-counter drugs, should be disclosed to a healthcare professional.


Q: Does Theoplus interact with birth control pills?

Yes, official regulatory documents indicate that certain hormonal contraceptives may increase the concentration of the active substance in the bloodstream. This is due to their effect on the liver enzymes responsible for drug breakdown.


Q: What happens if I forget to take a dose of Theoplus?

Official administration guidelines describe that for immediate-release forms, the dose is taken as soon as it is remembered. However, if the next scheduled dose is very close, the missed dose is typically skipped, and the patient resumes the regular schedule.


Q: Does Theoplus affect blood sugar levels?

Yes, official documentation lists Hyperglycemia, which is the medical term for high blood sugar, as an officially documented adverse reaction. This is categorized under the Metabolism System-Organ Class.


Q: Are there any required tests or monitoring while taking Theoplus?

Due to the narrow therapeutic range of the active substance, official guidelines note that dose adjustments are formally guided by the required measurement of serum theophylline concentrations in the bloodstream.


Q: Can I drink coffee or caffeine while taking Theoplus?

Theophylline is a type of methylxanthine derivative, and co-administration with other methylxanthines, such as high caffeine intake, may lead to an additive pharmacodynamic effect, increasing the potential for adverse effects. Official documents describe that this combination may lead to an additive pharmacodynamic effect, increasing the potential for adverse effects.


Q: Does Theoplus interact with herbal supplements like St. John's Wort?

Official documentation explicitly lists St. John’s Wort as an interacting agent. This herbal supplement can cause a decreased concentration of the active substance in the bloodstream by increasing the rate at which the body breaks down the drug.


Q: Is Theoplus safe for women who are planning to become pregnant?

The medicine is classified by the US FDA as Pregnancy Category C. This classification indicates that the medicine should be used only if the potential benefit justifies the potential risk to the fetus, which requires careful consideration for use during or immediately prior to conception.


Q: Can older adults use Theoplus safely?

Official regulatory labeling defines conditional use for older adults, typically over 60 years of age. This is due to documented decreased drug clearance, which increases the risk of toxicity. The conditional use for this population requires the use of reduced doses and close attention to the patient’s clinical status.

How should Theoplus be stored and disposed of?

Official Storage and Disposal Requirements

Storage and disposal instructions for Theoplus (Choline Theophyllinate) are based on regulatory labeling to maintain product stability and ensure public safety.

Storage Conditions

Requirement Official Instruction
Temperature Store at Controlled Room Temperature (20 C to 25 C).
Protection Keep protected from excessive heat and moisture; do not freeze.
Container Rule Must be kept in the original container and kept tightly closed.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

Unused or expired Theoplus must be handled as pharmaceutical waste. Dispose of the medication according to local requirements and official protocols. Regulatory documents explicitly instruct users not to throw the medicine into general household waste or flush it down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Theoplus found in:

A-Z Index: